Therapeutic potential of PMEA as an antiviral drug

This publication has 69 references indexed in Scilit:

• Activity of the anti-HIV agent 9-(2-phosphonyl-methoxyethyl)-2,6-diaminopurine against cytomegalovirus in vitro and in vivo
  European Journal of Clinical Microbiology & Infectious Diseases, 1993
• Use of two virustatica (AZT, PMEA) in the treatment of FIV and of FeLV seropositive cats with clinical symptoms
  Veterinary Immunology and Immunopathology, 1992
• Phosphonylmethoxyalkyl purine and pyrimidine derivatives for treatment of opportunistic cytomegalovirus and herpes simplex virus infections in murine AIDS
  Antiviral Research, 1991
• Activity of acyclic nucleoside phosphonate analogues against human immunodeficiency virus in monocyte/macrophages and peripheral blood lymphocytes
  Biochemical and Biophysical Research Communications, 1991
• Drug targeting: Anti-HSV-1 activity of mannosylated polymer-bound 9-(2-phosphonylmethoxyethyl)adenine
  Biochemical and Biophysical Research Communications, 1990
• 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP): A novel agent with anti-human immunodeficiency virus activity in vitro and potent anti-moloney murine sarcoma virus activity in vivo
  European Journal of Clinical Microbiology & Infectious Diseases, 1989
• Synthesis and Biological Activities of Phosphonylalkylpurine Derivatives
  Nucleosides, Nucleotides and Nucleic Acids, 1989
• Phosphonylmethoxyalkylpurines and -pyrimidines as inhibitors of African swine fever virus replication in vitro
  Antiviral Research, 1987
• The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
  New England Journal of Medicine, 1987
• Comparative efficacy of broad-spectrum antiviral agents as inhibitors of African swine fever virus replication in vitro
  Antiviral Research, 1987